PT1395582E - Novos derivados de piperidinocarboxamida, metodo para a sua preparacao e composicoes farmaceuticas que os contem - Google Patents

Novos derivados de piperidinocarboxamida, metodo para a sua preparacao e composicoes farmaceuticas que os contem

Info

Publication number: PT1395582E
Authority: PT; Portugal
Prior art keywords: piperidinocarboxamide; derivatives; preparation; new; pharmaceutical compositions
Prior art date: 2001-05-21

Application number

PT02738257T

Other languages

English (en)

Inventor

Vincenzo Proietto

Xavier Emonds-Alt

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-21

Filing date

2002-05-17

Publication date

2005-08-31

2002-05-17 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2005-08-31 Publication of PT1395582E publication Critical patent/PT1395582E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Virology (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Communicable Diseases (AREA)
Endocrinology (AREA)
Anesthesiology (AREA)
Molecular Biology (AREA)

PT02738257T 2001-05-21 2002-05-17 Novos derivados de piperidinocarboxamida, metodo para a sua preparacao e composicoes farmaceuticas que os contem PT1395582E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0106691A FR2824828B1 (fr)	2001-05-21	2001-05-21	Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number	Publication Date
PT1395582E true PT1395582E (pt)	2005-08-31

Family

ID=8863515

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT02738257T PT1395582E (pt)	2001-05-21	2002-05-17	Novos derivados de piperidinocarboxamida, metodo para a sua preparacao e composicoes farmaceuticas que os contem

Country Status (36)

Country	Link
US (2)	US20040180890A1 (pt)
EP (1)	EP1395582B1 (pt)
JP (1)	JP2004529968A (pt)
KR (1)	KR20030097886A (pt)
CN (1)	CN1249059C (pt)
AR (1)	AR035247A1 (pt)
AT (1)	ATE294798T1 (pt)
AU (1)	AU2002313065B2 (pt)
BG (1)	BG108341A (pt)
BR (1)	BR0209877A (pt)
CA (1)	CA2445631A1 (pt)
CZ (1)	CZ20033132A3 (pt)
DE (1)	DE60204015T2 (pt)
DK (1)	DK1395582T3 (pt)
EA (1)	EA006236B1 (pt)
EE (1)	EE200300553A (pt)
ES (1)	ES2242032T3 (pt)
FR (1)	FR2824828B1 (pt)
HK (1)	HK1060129A1 (pt)
HR (1)	HRP20030923A2 (pt)
HU (1)	HUP0401563A2 (pt)
IL (1)	IL158660A0 (pt)
IS (1)	IS7008A (pt)
MA (1)	MA27022A1 (pt)
MX (1)	MXPA03010133A (pt)
NO (1)	NO20035163D0 (pt)
NZ (1)	NZ529206A (pt)
PL (1)	PL367341A1 (pt)
PT (1)	PT1395582E (pt)
SK (1)	SK14192003A3 (pt)
TN (1)	TNSN03118A1 (pt)
TW (1)	TWI258480B (pt)
UA (1)	UA75400C2 (pt)
WO (1)	WO2002094821A1 (pt)
YU (1)	YU86603A (pt)
ZA (1)	ZA200308344B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2312856T3 (es) *	2002-12-13	2009-03-01	Smithkline Beecham Corporation	Compuestos heterociclicos como antagonistas de ccr5.
FR2873373B1 (fr) *	2004-07-23	2006-09-08	Sanofi Synthelabo	Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
AU2007211475A1 (en) *	2006-02-01	2007-08-09	Solvay Pharmaceuticals Gmbh	Novel dual NK2/NK3-antagonists, pharmaceutical compositions comprising them and processes for their preparations
US20070219214A1 (en) *	2006-02-01	2007-09-20	Solvay Pharmaceuticals Gmbh	Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation
FR2912058A1 (fr) *	2007-02-07	2008-08-08	Sanofi Aventis Sa	Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles
EP2244716B1 (en) *	2008-01-11	2019-09-25	United Paragon Associates Inc.	Fertilized egg isolate and use thereof
US20110152233A1 (en) *	2009-12-18	2011-06-23	Henner Knust	Pyrrolidine compounds
CA2792539C (en) *	2010-03-11	2017-04-18	Megumi Maruyama	N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
EP3915560A1 (en)	2014-06-25	2021-12-01	Emory University	Methods of managing conditioned fear with neurokinin receptor antagonists
WO2020101017A1 (ja) *	2018-11-15	2020-05-22	国立大学法人九州大学	Ｉｌ－３１介在性疾患の予防又は治療剤及び医薬組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5689663A (en) *	1992-06-19	1997-11-18	Microsoft Corporation	Remote controller user interface and methods relating thereto
US5780466A (en) *	1995-01-30	1998-07-14	Sanofi	Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
FR2729954B1 (fr) *	1995-01-30	1997-08-01	Sanofi Sa	Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2738819B1 (fr) *	1995-09-14	1997-12-05	Sanofi Sa	Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
RU2135494C1 (ru) *	1995-12-01	1999-08-27	Санкио Компани Лимитед	Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина
JP3192631B2 (ja) *	1997-05-28	2001-07-30	三共株式会社	飽和複素環化合物からなる医薬
TR200001622T2 (tr) *	1997-12-04	2001-07-23	Sankyo Company Limited	Asilatlı Hetero-Alisiklik Türevleri
WO2000034274A1 (fr) *	1998-12-10	2000-06-15	Sankyo Company, Limited	Derives de la cyclohexylpiperidine
FR2791346B3 (fr) *	1999-03-25	2001-04-27	Sanofi Sa	Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant

2001
- 2001-05-21 FR FR0106691A patent/FR2824828B1/fr not_active Expired - Fee Related
2002
- 2002-05-17 IL IL15866002A patent/IL158660A0/xx not_active IP Right Cessation
- 2002-05-17 DK DK02738257T patent/DK1395582T3/da active
- 2002-05-17 DE DE60204015T patent/DE60204015T2/de not_active Expired - Fee Related
- 2002-05-17 WO PCT/FR2002/001663 patent/WO2002094821A1/fr active IP Right Grant
- 2002-05-17 EE EEP200300553A patent/EE200300553A/xx unknown
- 2002-05-17 CN CNB028124529A patent/CN1249059C/zh not_active Expired - Fee Related
- 2002-05-17 BR BR0209877-6A patent/BR0209877A/pt not_active IP Right Cessation
- 2002-05-17 ES ES02738257T patent/ES2242032T3/es not_active Expired - Lifetime
- 2002-05-17 CA CA002445631A patent/CA2445631A1/fr not_active Abandoned
- 2002-05-17 PL PL02367341A patent/PL367341A1/xx not_active Application Discontinuation
- 2002-05-17 SK SK1419-2003A patent/SK14192003A3/sk unknown
- 2002-05-17 AU AU2002313065A patent/AU2002313065B2/en not_active Ceased
- 2002-05-17 CZ CZ20033132A patent/CZ20033132A3/cs unknown
- 2002-05-17 KR KR10-2003-7015099A patent/KR20030097886A/ko active IP Right Grant
- 2002-05-17 UA UA2003109761A patent/UA75400C2/uk unknown
- 2002-05-17 NZ NZ529206A patent/NZ529206A/en unknown
- 2002-05-17 HU HU0401563A patent/HUP0401563A2/hu unknown
- 2002-05-17 EP EP02738257A patent/EP1395582B1/fr not_active Expired - Lifetime
- 2002-05-17 AT AT02738257T patent/ATE294798T1/de not_active IP Right Cessation
- 2002-05-17 PT PT02738257T patent/PT1395582E/pt unknown
- 2002-05-17 JP JP2002591494A patent/JP2004529968A/ja active Pending
- 2002-05-17 YU YU86603A patent/YU86603A/sh unknown
- 2002-05-17 EA EA200301087A patent/EA006236B1/ru not_active IP Right Cessation
- 2002-05-17 TN TNPCT/FR2002/001663A patent/TNSN03118A1/fr unknown
- 2002-05-17 US US10/477,682 patent/US20040180890A1/en not_active Abandoned
- 2002-05-17 MX MXPA03010133A patent/MXPA03010133A/es active IP Right Grant
- 2002-05-20 TW TW091110506A patent/TWI258480B/zh not_active IP Right Cessation
- 2002-05-21 AR ARP020101870A patent/AR035247A1/es unknown
2003
- 2003-10-27 ZA ZA200308344A patent/ZA200308344B/en unknown
- 2003-10-30 IS IS7008A patent/IS7008A/is unknown
- 2003-11-10 BG BG108341A patent/BG108341A/bg unknown
- 2003-11-12 HR HR20030923A patent/HRP20030923A2/hr not_active Application Discontinuation
- 2003-11-14 MA MA27396A patent/MA27022A1/fr unknown
- 2003-11-20 NO NO20035163A patent/NO20035163D0/no not_active Application Discontinuation
2004
- 2004-05-04 HK HK04103130A patent/HK1060129A1/xx not_active IP Right Cessation
2008
- 2008-06-03 US US12/131,999 patent/US20080261976A1/en not_active Abandoned

Also Published As

Publication number	Publication date
YU86603A (sh)	2006-05-25
ZA200308344B (en)	2004-10-27
AU2002313065B2 (en)	2007-06-28
NO20035163D0 (no)	2003-11-20
EA006236B1 (ru)	2005-10-27
ATE294798T1 (de)	2005-05-15
EE200300553A (et)	2004-02-16
NZ529206A (en)	2005-09-30
ES2242032T3 (es)	2005-11-01
US20080261976A1 (en)	2008-10-23
IS7008A (is)	2003-10-30
CN1518549A (zh)	2004-08-04
AR035247A1 (es)	2004-05-05
DK1395582T3 (da)	2005-08-29
EA200301087A1 (ru)	2004-04-29
US20040180890A1 (en)	2004-09-16
WO2002094821A1 (fr)	2002-11-28
IL158660A0 (en)	2004-05-12
MXPA03010133A (es)	2005-03-31
BR0209877A (pt)	2004-06-08
CN1249059C (zh)	2006-04-05
DE60204015T2 (de)	2006-01-12
HUP0401563A2 (hu)	2004-12-28
BG108341A (bg)	2004-12-30
FR2824828B1 (fr)	2005-05-20
HRP20030923A2 (en)	2004-02-29
UA75400C2 (en)	2006-04-17
CA2445631A1 (fr)	2002-11-28
SK14192003A3 (sk)	2004-06-08
CZ20033132A3 (cs)	2004-02-18
DE60204015D1 (de)	2005-06-09
FR2824828A1 (fr)	2002-11-22
HK1060129A1 (en)	2004-07-30
MA27022A1 (fr)	2004-12-20
KR20030097886A (ko)	2003-12-31
PL367341A1 (en)	2005-02-21
EP1395582A1 (fr)	2004-03-10
TWI258480B (en)	2006-07-21
JP2004529968A (ja)	2004-09-30
EP1395582B1 (fr)	2005-05-04
TNSN03118A1 (fr)	2005-12-23

Publication	Publication Date	Title
PT1339675E (pt)	2005-04-29	Compostos bisarilo orto, meta-substituidos, processo para a sua preparacao, sua utilizacao como medicamentos e composicoes farmaceuticas que os contem
PT1202965E (pt)	2005-01-31	Derivados de indol processos para a sua preparacao composicoes farmaceuticas que os contem e a sua aplicacao
PT1192122E (pt)	2004-03-31	Derivados de benzeno processo para a sua preparacao e composicoes farmaceuticas que os contem
BR0008840B1 (pt)	2011-12-27	derivados de camptotecina, processos para a sua preparaÇço, composiÇço farmacÊutica que os compreende e uso dos mesmos.
PT1150961E (pt)	2004-02-27	Derivados do acido pirazolecarboxilico processo para a sua preparacao e as composicoes farmaceuticas que os contem
BR0017030B1 (pt)	2013-10-01	derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos
BR9910900B1 (pt)	2013-09-17	compostos derivados de isotiazol, processo para sua preparação e composição farmacêutica dos mesmos
EE05104B1 (et)	2008-12-15	Asetidiini derivaadid, nende valmistamise meetodid ja farmatseutiline kompositsioon
PT1112266E (pt)	2003-09-30	4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem.
BR9801606B1 (pt)	2010-07-27	composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica.
PT885204E (pt)	2002-10-31	Novos derivados de arilglicinamida, processo para a sua preparacao e composicoes farmaceuticas que contem estes compostos
PT973763E (pt)	2003-10-31	Novos derivados do 2-(iminometil)amino-fenilo, sua preparacao, sua aplicacao na qualidade de medicamentos e composicoes farmaceuticas que os contem
PT1122254E (pt)	2005-07-29	Derivados de 4-sulfonamidas piperidina, processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1395582E (pt)	2005-08-31	Novos derivados de piperidinocarboxamida, metodo para a sua preparacao e composicoes farmaceuticas que os contem
PT1118610E (pt)	2002-11-29	Novos derivados de benzeno-sulfonamida processo para a sua preparacao e as composicoes farmaceuticas que os contem
AR026072A1 (es)	2002-12-26	Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
PT1049706E (pt)	2003-09-30	Novos penta-sacaridos os respectivos metodos de producao e as composicoes farmaceuticas que os contem
PT1224210E (pt)	2004-04-30	Compostos monociclicos basicos tendo accao antagonista de nk-2 processos para a sua preparacao e formulacoes que os contem
PT1165528E (pt)	2005-01-31	Novos derivados de morfolina, processo para a sua preparacao e composicoes farmaceuticas que os contem
PT1242389E (pt)	2004-08-31	Novos derivados ramificados de 3-amino-1-fenil-h¬1,2,4\|pirazole substituidos em amino processos para a sua preparacao e composicoes farmaceuticas que os contem
BR1100524A (pt)	2000-03-14	Compostos, processo para sua preparação; compostos intermediários para os mesmos, e composições farmacêuticas
PT1275647E (pt)	2004-03-31	Derivados de octa-hidro-2h-pirido¬1,2-a\|pirazina processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1245565E (pt)	2003-12-31	Derivados de indenoindolonas processo para a sua preparacao e as composicoes farmaceuticas que os contem
NO20004638L (no)	2000-11-16	Hypnotisk <beta>- karbolinderivater, fremgangsmÕte til deres fremstilling og deres anvendelse som legemiddelprodukt
PT1411057E (pt)	2005-08-31	Derivados de [3,4-a:3,4-c]carbazole processo para a sua preparacao e as composicoes farmaceuticas que os contem